Efficacy and Safety of PF-06291874 (PF), a Glucagon Receptor Antagonist Administered for 12 Weeks to Patients with Type 2 Diabetes Mellitus (T2DM) on Background Metformin TherapyRoberto A. Calle,Arthur Bergman,Veena Somayaji,Kristin Chidsey,David J. KazieradDIABETES（2017）引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
